Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) vs Freedom Metals Acquisition Corp. (FDMM)

A side-by-side comparison of Drugs Made In America Acquisition Corp. Ordinary Shares and Freedom Metals Acquisition Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Drugs Made In America Acquisition Corp. Ordinary Shares logo
DMAA
Drugs Made In America Acquisition Corp. Ordinary Shares
$265M
$10.90Financial ServicesDelayed quote: Oct 5, 2026, 1:49 PM EDT
Freedom Metals Acquisition Corp. logo
FDMM
Freedom Metals Acquisition Corp.
$271M
$9.84Financial ServicesDelayed quote: Oct 5, 2026, 10:23 AM EDT

Total return — DMAA vs FDMM

growth of $100 · dividends reinvested · last 1y
DMAA +1.7% (+1.7%/yr)FDMM -0.3% (-0.3%/yr)DMAA compounded faster over this window
100100101101102Start $100$102$100
DMAA FDMM

Metrics side by side

Total return (annualized)

MetricDMAAFDMM
Total return (1Y)6.01%N/A

FDMM is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full DMAA analysisFull FDMM analysisInteractive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.